| GTO ID | GTC3247 |
| Trial ID | NCT05627323 |
| Disease | Brain Glioblastoma Multiforme |
| Altered gene | CLTX |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CHM-1101 |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | CAR T Cells in Patients With MMP2+ Recurrent or Progressive Glioblastoma |
| Year | 2022 |
| Country | United States |
| Company sponsor | Chimeric Therapeutics |
| Other ID(s) | CHM-1101-001 |
| Cohort 1 | |||||||||
|
|||||||||